Tuesday, 19 September 2017

Glenmark Pharma gets ANDA approval for Nitroglycerin Sublingual tablets

Sub: Glenmark Pharmaceuticals receives ANDA approval for Nitroglycerin Sublingual Tablets USP, 0.3 mg, 0.4 mg, and 0.6 mg

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.

Source : BSE


Source: Glenmark Pharma gets ANDA approval for Nitroglycerin Sublingual tablets

No comments:

Post a Comment